Locations

LA JOLLA

Private financing in LA JOLLA, aggregated from public sources.

$2.6B
Capital raised
117
Companies
238
Rounds
2007
First on record
2026-06-30
Latest round

Steady LA JOLLA drew $61.2M over the last 12 months, down 9% versus the prior 12 ($67.0M). Of 115 companies rankable against same-niche peers, 30% model over-valued and 25% under-valued.

Capital flow over time

Quarterly capital raised in LA JOLLA.

2008-Q1 · $11.2M2008-Q12008-Q2 · $2.5M2008-Q3 · $1.6M2008-Q4 · $39.9M2009-Q1 · $10.0M2009-Q2 · $19.0M2009-Q3 · $2.9M2009-Q32009-Q4 · $19.5M2010-Q1 · $7.9M2010-Q2 · $46.7M2010-Q3 · $55.1M2010-Q4 · $1.0M2011-Q1 · $1.4M2011-Q12011-Q2 · $2.5M2011-Q3 · $4.2M2011-Q4 · $7.0M2012-Q1 · $20.8M2012-Q3 · $41.8M2012-Q4 · $55.2M2012-Q42013-Q1 · $10.5M2013-Q2 · $5.9M2013-Q3 · $13.5M2013-Q4 · $2.5M2014-Q1 · $25.3M2014-Q2 · $24.8M2014-Q22014-Q3 · $35.2M2014-Q4 · $7.5M2015-Q1 · $74.5M2015-Q2 · $18.6M2015-Q3 · $64.7M2015-Q4 · $7.0M2015-Q42016-Q1 · $264.0M2016-Q2 · $75.4M2016-Q3 · $8.0M2016-Q4 · $29.0M2017-Q1 · $50.6M2017-Q2 · $11.6M2017-Q22017-Q3 · $85.5M2017-Q4 · $2.0M2018-Q2 · $441.9M2018-Q3 · $512K2018-Q4 · $38.0M2019-Q1 · $1.5M2019-Q12019-Q2 · $45.8M2019-Q3 · $78.3M2019-Q4 · $44.5M2020-Q1 · $65.5M2020-Q2 · $35.2M2020-Q3 · $27.9M2020-Q32020-Q4 · $17.2M2021-Q1 · $36.1M2021-Q2 · $8.1M2021-Q3 · $54.5M2021-Q4 · $6.7M2022-Q1 · $6.2M2022-Q12022-Q2 · $12.4M2022-Q3 · $8.4M2022-Q4 · $29.0M2023-Q1 · $24.6M2023-Q2 · $39.3M2023-Q3 · $200.0M2023-Q32024-Q1 · $4.7M2024-Q2 · $94.0M2024-Q3 · $29.9M2024-Q4 · $762K2025-Q1 · $12.6M2025-Q2 · $23.7M2025-Q22025-Q3 · $25.4M2025-Q4 · $25.4M2026-Q2 · $10.5M
Sector mix
SectorCompaniesRoundsCapital
Biotechnology2261$1.2B
Pharmaceuticals1024$605.6M
Other Health Care1127$256.2M
Other2854$212.8M
Other Technology1213$103.1M
Biotech / Pharma313$88.0M
Other Energy13$55.0M
Software / Tech35$36.6M
Top-funded companies
CompanySectorRaisedModeled value
Inhibrx, Inc.Biotechnology$668.6M$3.3B
Ligand Pharmaceuticals IncPharmaceuticals$85.4M$3.0B
Arena Holdings, Inc.Other Technology$85.5M$2.7B
Kura Operations, Inc.Biotechnology$63.4M$2.5B
Orexigen Therapeutics, Inc.Pharmaceuticals$274.6M$1.8B
DermTech, Inc.Other Health Care$98.9M$1.5B
Synthorx, Inc.Biotechnology$34.7M$1.1B
Auspex Pharmaceuticals, Inc.Pharmaceuticals$82.8M$951.9M
Cell MDX, LLCOther Health Care$40.0M$885.5M
4Paws Dx, Inc.Other Health Care$69.1M$779.8M
Intellikine, Inc.Biotechnology$16.0M$636.4M
Aira Tech Corp.Software / Tech$32.2M$522.6M
Regency Terranea Investor, LLCOther$25.8M$429.1M
Boffo Investors, LLCOther$34.5M$415.4M
Impact Genomics, Inc.Biotech$10.2M$369.3M
Ambrx IncBiotechnology$10.0M$361.5M
Nex Cubed, LLCOther$15.7M$260.4M
Ankasa Regenerative Therapeutics, Inc.Biotechnology$15.5M$192.2M
Sophiris Bio Inc.Biotechnology$5.1M$183.2M
Rocket Parent, LLCOther$12.1M$182.4M
Other locations

Browse all locations or the full company rankings.

Frequently asked
How much venture funding have companies in LA JOLLA raised?
Companies based in LA JOLLA have raised approximately $2.6B across 238 recorded financing rounds among 117 companies, aggregated from public sources.
Is startup funding in LA JOLLA growing?
LA JOLLA funding is currently steady: capital raised over the last 12 months was down 9% versus the prior 12 months.
What sectors are most active in LA JOLLA?
The most active sectors in LA JOLLA by recorded financing are Biotechnology, Pharmaceuticals, Other Health Care, Other. See the sector mix table for company and round counts.
Which are the most-funded companies in LA JOLLA?
The most-funded LA JOLLA companies in our coverage include Inhibrx, Inc., Ligand Pharmaceuticals Inc, Arena Holdings, Inc., Kura Operations, Inc., Orexigen Therapeutics, Inc.. See the ranked table for disclosed capital and modeled valuations.